REPORT ID 3801

EMEA (Europe, Middle East and Africa) Methadone Market Report 2017

Publish Date
14-Dec-17
Pages
103
Format
Electronic (PDF)

In this report, the EMEA Methadone market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Methadone for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Methadone market competition by top manufacturers/players, with Methadone sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Roxane (Boehringer Ingelheim)
    Mallinckrodt
    VistaPharm
    Dolophine
    Methadoes
    Diskets
    Macfarlan Smith
    CentralPharm
    Qinghai Pharm

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Oral Medicine
    Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Operation
    Detoxification
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Methadone Market Report 2017
1 Methadone Overview
    1.1 Product Overview and Scope of Methadone
    1.2 Classification of Methadone
        1.2.1 EMEA Methadone Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Methadone Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Oral Medicine
        1.2.4 Injection
    1.3 EMEA Methadone Market by Application/End Users
        1.3.1 EMEA Methadone Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Operation
        1.3.3 Detoxification
        1.3.4 Other
    1.4 EMEA Methadone Market by Region
        1.4.1 EMEA Methadone Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Methadone (2012-2022)
        1.5.1 EMEA Methadone Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Methadone Revenue and Growth Rate (2012-2022)

2 EMEA Methadone Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Methadone Market Competition by Players/Manufacturers
        2.1.1 EMEA Methadone Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Methadone Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Methadone Sale Price by Players (2012-2017)
    2.2 EMEA Methadone (Volume and Value) by Type/Product Category
        2.2.1 EMEA Methadone Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Methadone Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Methadone Sale Price by Type (2012-2017)
    2.3 EMEA Methadone (Volume) by Application
    2.4 EMEA Methadone (Volume and Value) by Region
        2.4.1 EMEA Methadone Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Methadone Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Methadone Sales Price by Region (2012-2017)

3 Europe Methadone (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Methadone Sales and Value (2012-2017)
        3.1.1 Europe Methadone Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Methadone Revenue and Growth Rate (2012-2017)
    3.2 Europe Methadone Sales and Market Share by Type
    3.3 Europe Methadone Sales and Market Share by Application
    3.4 Europe Methadone Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Methadone Sales Volume by Countries (2012-2017)
        3.4.2 Europe Methadone Revenue by Countries (2012-2017)
        3.4.3 Germany Methadone Sales and Growth Rate (2012-2017)
        3.4.4 France Methadone Sales and Growth Rate (2012-2017)
        3.4.5 UK Methadone Sales and Growth Rate (2012-2017)
        3.4.6 Russia Methadone Sales and Growth Rate (2012-2017)
        3.4.7 Italy Methadone Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Methadone Sales and Growth Rate (2012-2017)

4 Middle East Methadone (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Methadone Sales and Value (2012-2017)
        4.1.1 Middle East Methadone Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Methadone Revenue and Growth Rate (2012-2017)
    4.2 Middle East Methadone Sales and Market Share by Type
    4.3 Middle East Methadone Sales and Market Share by Application
    4.4 Middle East Methadone Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Methadone Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Methadone Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Methadone Sales and Growth Rate (2012-2017)
        4.4.4 Israel Methadone Sales and Growth Rate (2012-2017)
        4.4.5 UAE Methadone Sales and Growth Rate (2012-2017)
        4.4.6 Iran Methadone Sales and Growth Rate (2012-2017)

5 Africa Methadone (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Methadone Sales and Value (2012-2017)
        5.1.1 Africa Methadone Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Methadone Revenue and Growth Rate (2012-2017)
    5.2 Africa Methadone Sales and Market Share by Type
    5.3 Africa Methadone Sales and Market Share by Application
    5.4 Africa Methadone Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Methadone Sales Volume by Countries (2012-2017)
        5.4.2 Africa Methadone Revenue by Countries (2012-2017)
        5.4.3 South Africa Methadone Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Methadone Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Methadone Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Methadone Sales and Growth Rate (2012-2017)

6 EMEA Methadone Manufacturers/Players Profiles and Sales Data
    6.1 Roxane (Boehringer Ingelheim)
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Methadone Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Roxane (Boehringer Ingelheim) Methadone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Mallinckrodt
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Methadone Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Mallinckrodt Methadone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 VistaPharm
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Methadone Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 VistaPharm Methadone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Dolophine
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Methadone Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Dolophine Methadone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Methadoes
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Methadone Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Methadoes Methadone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Diskets
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Methadone Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Diskets Methadone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Macfarlan Smith
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Methadone Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Macfarlan Smith Methadone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 CentralPharm
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Methadone Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 CentralPharm Methadone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Qinghai Pharm
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Methadone Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Qinghai Pharm Methadone Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview

7 Methadone Manufacturing Cost Analysis
    7.1 Methadone Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Methadone

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Methadone Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Methadone Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Methadone Market Forecast (2017-2022)
    11.1 EMEA Methadone Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Methadone Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Methadone Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Methadone Price and Trend Forecast (2017-2022)
    11.2 EMEA Methadone Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Methadone Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Methadone Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Methadone Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Methadone Sales Forecast by Type (2017-2022)
    11.7 EMEA Methadone Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer